Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant Hirudin

recombinant hirudin · MinaPharm Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant Hirudin, covering 2023-05-06 to 2023-05-06. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluation of Recombinant Hirudin in Prophylaxis of Post-Operative Deep Vein Thrombosis [Phase 4]

See pricing